T Cell-Loaded Injectable Chitosan Scaffold Shows Short-Term Efficacy in Localized Cancer Immunotherapy in Mice

Researchers hypothesized that localized T cell delivery in an in situ gelling chitosan hydrogel will allow similar treatment efficacy despite delivering fewer cells than systemic intravenous delivery.